National
DNC 2012: Jubilant LGBT delegates vow to support Obama
White House official, HHS Secretary among speakers at Caucus meeting
‘With a change in the White House much of the litany of what you’ve just heard is gone,’ said HHS Secretary Kathleen Sebelius said after listing some of President Obama’s LGBT-related accomplishments.
CHARLOTTE, N.C. — Hours before the Democratic National Convention’s opening session was called to order Tuesday night, a record number of more than 550 LGBT delegates, alternate delegates and convention committee members met as a recognized convention caucus.
Valerie Jarrett, White House Senior Adviser to the President; Kathleen Sebelius, Secretary of the U.S. Department of Health and Human Services; and Tammy Baldwin, the lesbian Democratic House member from Wisconsin who’s running for the U.S. Senate, were among a parade of elected officials and Democratic Party leaders to speak at the caucus meeting.
While greeting each of the speakers with loud applause, many of the LGBT delegates and convention participants said the big news of the day was the size of their caucus and its growth over the past two decades.
“History is being made this week,” said Minnesota gay delegate Rick Stafford, who serves as chair of the LGBT Caucus. “There’s over 550 LGBT Americans who are an official part of the 2012 Democratic National Convention.”
Stafford said that for the first time all 50 states have sent at least one or more LGBT delegates to a Democratic convention.
“Please let everyone know we are here to be seen and heard,” said Brandon Marcus, an out gay member of the North Carolina House of Representatives and one of 12 LGBT delegates and alternates from the Tar Heel state.
‘With your efforts we have been able to move our country forward,’ said Valerie Jarrett, White House senior adviser.
Marcus, who said he was proud to welcome his fellow LGBT convention participants to his home state, said he was certain that the cause for LGBT equality in North Carolina advanced this year despite the fact that voters passed Amendment 1, which added a provision to the state constitution banning same-sex marriage.
“The cause was not lost with Amendment 1,” he said.
Jarrett said efforts by the LGBT Caucus members and their supporters throughout the country on behalf of LGBT rights made it possible for the Obama administration to move forward with the president’s legislative and executive office initiatives on LGBT equality.
“With your efforts we have been able to move our country forward, I believe, in a fair way that respects everybody’s rights,” she said. “And that’s something that’s the foundation of our country and it’s something we can’t take for granted. We have to fight for it and make our country the more perfect union we know it can be.”
Jarrett received a prolonged, standing ovation when she added, “And I believe we are a more perfect union than we were four years ago.”
Sebelius said the repeal of the “Don’t Ask, Don’t Tell” law, which banned gays from serving openly in the military, and the passage by Congress of the Matthew Shepard and James Byrd Jr. Hate Crimes Prevention Act, which authorizes the federal government to prosecute anti-LGBT hate crimes, were an important part of the president’s legislative proposals.
But she said that due to opposition from the Republican-controlled House, most of the Obama administration’s achievements on LGBT rights came from directives from the president and federal agencies and departments under the president’s control.
Non-discrimination polices in federal housing programs, hospital visitation rights for same-sex partners, a ban on employment discrimination for transgender people in the federal workforce are among many of the Obama administration’s LGBT-related initiatives, members of the LGBT Caucus said.
“A lot of what you heard about today is not the law of the land,” Sebelius said. “It really is administrative rules and regulations that are in place and which can be wiped out in a heartbeat. With a change in the White House much of the litany of what you’ve just heard is gone.”
She said one task that LGBT Caucus members could take on to help ensure Obama’s re-election is to reach out to younger voters who support LGBT equality and other progressive causes in large numbers but who often don’t turn out to vote.
“Younger voters are enthusiastically in favor of equality for all,” she said. “But too many of them are not yet engaged in this election. They’re our voters but they are kind of sitting on the sidelines.
“So one of the things that has to be done in the next 63 days is, first, make sure they are registered and secondly get them to vote. And you all have a great microphone to do that – to talk to them about the LGBT issues at stake,” Sebelius said.
Baldwin is scheduled to address the convention Thursday night before President Obama and Vice President Joe Biden deliver their respective speeches. She told the LGBT Caucus she would provide needed support for the president’s initiatives on a wide range of issues, including LGBT equality and health care, if she wins her Senate race.
She said she believes she has a “very close” race against her GOP opponent, former Wisconsin Gov. Tommy Thompson.
Some political observers have said Thompson, considered a GOP moderate on social issues, emerged as the strongest Republican opponent to run against Baldwin when he won the GOP primary.
“An election is about who writes the rules and who benefits from them,” Baldwin said.
LGBT Caucus at the DNC (Blade photo by Michael Key)
Others who spoke before the LGBT Caucus meeting were Randi Weingarten, the lesbian president of the American Federation of Teachers; Brian Bond, the gay director of constituent outreach at the Democratic National Committee and former deputy director of the White House Office of Public Engagement; Andy Tobias, the gay DNC treasurer; Ray Buckley, the gay chair of the New Hampshire Democratic Party; and Steve Kerrigan, the gay CEO of the 2012 Democratic Convention.
A second LGBT Caucus meeting is scheduled to take place Thursday.
As of late Tuesday, convention officials had yet to release a list of the names of the LGBT Caucus members. The Democratic National Committee has not responded to a Washington Blade request for that list.
Stafford and Jerame Davis, executive director of the National Stonewall Democrats, said they have independently compiled their own list of LGBT Caucus members. They said they would consider releasing their lists but did not do so as of Tuesday.
Gay alternate delegate David Meadows of D.C. said he would raise objections to any decision by party officials to withhold the names of the LGBT delegates and other LGBT convention participants.
“All of us checked a box saying we were part of the LGBT community,” Meadows said. “All of us self-disclosed who we are. It makes no sense to withhold the names.”
Meadows was referring to a form that the DNC asked all state parties circulate to Democrats seeking to become delegates to the 2012 convention. The form was part of an effort to assess the party’s outreach to various minorities, including LGBT people.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
